Pain Management News and Research

RSS

House Judiciary Committee calls for another hearing to assess football-related brain injuries

Chairman of the House Judiciary Committee John Conyers has called for another hearing on brain injuries in football to be held on Monday, January 4.

4 Jan 2010

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere Technologies, Inc. today announced a meta-analysis published in the December 2009 edition of Rheumatology Reports examining independent evidence of the analgesic action of the hormone calcitonin. This publication restates the potential of calcitonin in filling a significant unmet need for alternative treatments for persistent musculoskeletal pain.

22 Dec 2009

CombinatoRx and Neuromed Pharmaceuticals complete merger agreement

CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc. announced today that they have merged. This merger brings together the product assets and financial resources of both organizations, including potential Exalgo™ milestone and royalty revenue, CombinatoRx’s portfolio of product candidates and unique drug discovery capabilities.

21 Dec 2009

2010 Dr. Paul Janssen Award for Biomedical Research open for nomination

The Dr. Paul Janssen Award for Biomedical Research has opened the 2010 call for nominations. The $100,000 Award recognizes individuals whose efforts have made significant transformational contributions towards the improvement of human health. Nomination forms are available at pauljanssenaward.com and will be accepted until February 15, 2010.

18 Dec 2009

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Lannett Company, Inc. today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg, the generic equivalent of Purdue Pharmaceuticals’ (formerly Abbott’s) Dilaudid® Tablets 2 mg, 4 mg and 8 mg.

11 Dec 2009

Tips to help patients become more active and involved in their health care

A visit to the doctor is a time to talk and learn, and patients play a critical role in their health care, just like doctors, nurses and other caregivers, according to The Joint Commission's "Tips for Your Doctor's Visit" Speak Up™ educational campaign.

10 Dec 2009

Opioids can be a safe and effective treatment for pain, shows study

A study published in the current issue of the Canadian Medical Association Journal (CMAJ) by Dhalla et al. has reviewed opioid-related deaths in Ontario from 1991 to 2004. The Canadian Pain Society (CPS) is very concerned that a small percentage of the population is misusing opioid analgesics, also called narcotic pain killers, resulting in harm and even death.

8 Dec 2009

The Cancer Center at Harrington receives approval to treat its first patients

The Cancer Center at Harrington has received approval to treat its first patients, Harrington Hospital announced today.

4 Dec 2009

Study on the genetics of osteoarthritis

Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.

2 Dec 2009

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.

2 Dec 2009

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.

2 Dec 2009

Survey and existing research reveal differences in pain management between genders

For many Canadians, December is the start of the holiday season and a time of joy and celebration, but for some, it can also be a time of increased aches and pains. Whether it's a backache from shoveling away the first snowfall, hanging holiday lights or a headache from the stress of holiday shopping, December brings a new set of aches and pains.

2 Dec 2009

Scientist honored with 2010 University of Louisville Grawemeyer Award for Psychology

A scientist who broadened the understanding of how we experience pain -- and ways we can control and relieve it -- has won the 2010 University of Louisville Grawemeyer Award for Psychology.

2 Dec 2009

Masimo Rainbow SET Acoustic Monitoring receives FDA clearance

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced FDA clearance of its latest innovation -- Masimo Rainbow SET Acoustic Monitoring(TM)( -- )providing noninvasive and continuous respiration rate (RRa(TM)) that is accurate, easy-to-use, and enhances patient compliance.

1 Dec 2009

Versa Card is now Spine Pain Management

Spine Pain Management, Inc. has officially changed its name from "Versa Card, Inc." to "Spine Pain Management, Inc." and has changed its trading symbol from "IGLB" to "SPIN." The name change was effected legally with the Delaware Secretary of State on November 12, 2009 and was effected in the market on November 27, 2009.

1 Dec 2009

Virtual Imaging to introduce latest imaging solutions and additions to its RadPRO product line

Virtual Imaging, Inc., a Canon U.S.A, Inc. company, will introduce the latest imaging solutions and additions to its RadPRO® product line at the 2009 Radiological Society of North America (RSNA 2009) Annual Meeting in Chicago November 29 – December 3 (Hall B, booth # 8339).

29 Nov 2009

New article discusses the balance between pain management and drug safety

An article by Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, titled "A Difficult Balance - Pain Management, Drug Safety, and the FDA," appears in the Nov. 26, 2009 issue of The New England Journal of Medicine.

26 Nov 2009

First-quarter fiscal 2010 results announced by China Aoxing Pharmaceutical

China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced financial and operational results for the three month ended September 30, 2009, or the first quarter of fiscal year 2010.

24 Nov 2009

DJO's new Moveo XP Rehabilitation Platform granted U.S. patent

DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that its Chattanooga division was issued U.S. Patent No. 7597656 for Chattanooga’s new Moveo XP Rehabilitation Platform. The Moveo XP is the first product of its kind, allowing patients who are incapable of supporting full body weight to participate in graded weight-bearing activity at an earlier stage in their physical rehabilitation.

24 Nov 2009

Lannett CEO to participate in NYSE opening bell ringing ceremony

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that President and Chief Executive Officer Arthur Bedrosian will ring the opening bell at the New York Stock Exchange at 9:30 a.m. Eastern on Monday, November 23, 2009.

23 Nov 2009